- Home
- ZION vs RGEN Comparison
ZION vs RGEN Comparison
Compare ZION & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZION
- RGEN
- Stock Information
- Founded
- ZION 1873
- RGEN 1981
- Country
- ZION United States
- RGEN United States
- Employees
- ZION N/A
- RGEN N/A
- Industry
- ZION Major Banks
- RGEN Medical/Dental Instruments
- Sector
- ZION Finance
- RGEN Health Care
- Exchange
- ZION Nasdaq
- RGEN Nasdaq
- Market Cap
- ZION 7.4B
- RGEN 7.1B
- IPO Year
- ZION N/A
- RGEN N/A
- Fundamental
- Price
- ZION $44.28
- RGEN $130.00
- Analyst Decision
- ZION Hold
- RGEN Buy
- Analyst Count
- ZION 22
- RGEN 12
- Target Price
- ZION $59.24
- RGEN $175.56
- AVG Volume (30 Days)
- ZION 2.6M
- RGEN 951.5K
- Earning Date
- ZION 04-21-2025
- RGEN 04-29-2025
- Dividend Yield
- ZION 3.89%
- RGEN N/A
- EPS Growth
- ZION 13.92
- RGEN N/A
- EPS
- ZION 4.95
- RGEN N/A
- Revenue
- ZION $3,058,000,000.00
- RGEN $634,439,000.00
- Revenue This Year
- ZION $9.81
- RGEN $12.29
- Revenue Next Year
- ZION $4.71
- RGEN $15.20
- P/E Ratio
- ZION $8.95
- RGEN N/A
- Revenue Growth
- ZION 2.51
- RGEN 0.33
- 52 Week Low
- ZION $39.05
- RGEN $102.97
- 52 Week High
- ZION $63.22
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- ZION 42.94
- RGEN 48.60
- Support Level
- ZION $42.77
- RGEN $105.06
- Resistance Level
- ZION $46.41
- RGEN $135.81
- Average True Range (ATR)
- ZION 2.77
- RGEN 9.95
- MACD
- ZION 0.02
- RGEN 1.83
- Stochastic Oscillator
- ZION 44.40
- RGEN 82.31
About ZION Zions Bancorporation N.A.
Zions Bancorporation is a regional us bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions primarily focuses on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.